Boehringer Ingelheim Venture Fund

A corporate venture capital fund investing in pioneering science to redefine patient care.

Venture Capital Active Ingelheim am Rhein, Germany Est. 2010
Last updated 2026-07-20
Portfolio
2
in our dataset
Rounds participated
3
Rounds led
1
Rounds' value
$140.5M
total disclosed, rounds participated
Stages
—

About

The Boehringer Ingelheim Venture Fund (BIVF) is the strategic corporate venture capital arm of Boehringer Ingelheim, established in 2010. It operates as a €350 million evergreen fund with a global presence in the EU, US, and China. BIVF invests in groundbreaking therapeutic approaches and technologies, focusing on first-in-class, disease-modifying therapeutics across various modalities. Their investment focus areas include cancer (immuno-oncology & targeted therapy), regenerative medicine, auto-immunity indications, digital solutions, and infectious diseases. BIVF takes a minority shareholder position and requires a voting board seat to actively support its portfolio companies.

Portfolio · 2

RiboX Therapeutics
Developer of fully engineered circular RNA therapeutics for various diseases.
Led ★ 1 round $110.0M committed Latest: 2022-07
Metabomed
Target-inhibiting Anticancer Drugs
2 rounds $30.5M committed Latest: 2019-12

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Boehringer Ingelheim Venture Fund's primary sector focus for investments?
Boehringer Ingelheim Venture Fund primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated in this area.
Can you name a notable portfolio company of Boehringer Ingelheim Venture Fund?
A notable portfolio company of Boehringer Ingelheim Venture Fund is Metabomed, which develops target-inhibiting anticancer drugs.
What was the funding stage and amount raised for Metabomed?
Metabomed, a portfolio company, raised a $30.5M Series A round.
When did Boehringer Ingelheim Venture Fund make its most recent recorded investment?
Boehringer Ingelheim Venture Fund made its most recent recorded investment in December 2019.
What is the typical investment range for Boehringer Ingelheim Venture Fund?
Boehringer Ingelheim Venture Fund's investment range is between $12.5M and $18M.
What is the geographic headquarters of Boehringer Ingelheim Venture Fund?
Boehringer Ingelheim Venture Fund is headquartered in Germany.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2010-3